Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.960
-0.010 (-0.51%)
Nov 13, 2026, 4:00 PM EST - Market closed

PACB Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
55.9163.7155.37179.91325.09460.73
Short-Term Investments
143.51215.8334.56451.51447.23583.68
Cash & Short-Term Investments
199.42279.51389.93631.42772.321,044
Cash Growth
-33.23%-28.32%-38.25%-18.24%-26.05%227.59%
Accounts Receivable
38.3235.4527.5236.6218.7924.24
Receivables
38.3235.4527.5236.6218.7924.24
Inventory
60.2849.2958.7656.6850.3824.6
Prepaid Expenses
9.810.7918.7817.0410.297.39
Restricted Cash
0.030.020.690.30.30.5
Total Current Assets
307.85375.05495.68742.05852.071,101
Property, Plant & Equipment
68.6965.8446.669.0381.3479.12
Goodwill
317.76317.76317.76462.26409.97409.97
Other Intangible Assets
12.1615.12389.57456.98410.25410.98
Other Long-Term Assets
14.6310.3110.8415.713.455.76
Total Assets
721.1784.081,2601,7461,7672,007

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
10.9220.7716.5915.0612.0311
Accrued Expenses
22.2126.9821.5144.7434.5839.27
Current Portion of Long-Term Debt
3--0.491.841.61
Current Portion of Leases
2.070.4510.039.598.897.71
Current Unearned Revenue
17.3415.9413.8616.3430.510.98
Other Current Liabilities
11.068.74.318.8175.51.15
Total Current Liabilities
66.5972.8366.395.03263.3471.71
Long-Term Debt
643.06645.38647.49892.24896.68896.07
Long-Term Leases
60.2456.5914.9131.6141.0749.97
Long-Term Unearned Revenue
4.233.935.95.531.7925.05
Other Long-Term Liabilities
8.35-19.2520.31.3173.19
Total Liabilities
782.48778.73753.851,0451,2041,216

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.310.30.290.270.230.22
Additional Paid-In Capital
2,7252,7002,6552,5402,1002,010
Retained Earnings
-2,786-2,695-2,149-1,839-1,532-1,218
Comprehensive Income & Other
-0.820.460.420.22-4.77-1.09
Shareholders' Equity
-61.385.35506.59701.3562.9790.99
Total Liabilities & Equity
721.1784.081,2601,7461,7672,007

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
708.37702.42672.43933.93948.48955.36
Net Cash (Debt)
-508.95-422.92-282.5-302.51-176.1689.05
Net Cash Growth
------67.83%
Net Cash Per Share
-1.66-1.41-1.03-1.19-0.780.44
Filing Date Shares Outstanding
312.93302297.85267.95247.08221.18
Total Common Shares Outstanding
312.24301.96294.42267.74226.51220.98
Working Capital
241.26302.22429.38647.02588.741,029
Book Value Per Share
-0.200.021.722.622.493.58
Tangible Book Value
-391.31-327.54-200.74-217.94-257.32-29.97
Tangible Book Value Per Share
-1.25-1.08-0.68-0.81-1.14-0.14
Machinery
-70.1769.1368.0360.8649.8
Construction In Progress
-5.412.281.344.72.3
Leasehold Improvements
-33.8433.7735.2334.1331.11
Order Backlog
-49.258.6---
SEC Filings: 10-K · 10-Q